VEGFA and Thrombocytopenia: Thus, we speculate that the beneficial effects of thalidomide on hypersplenism and thrombocytopenia may be due, at least in part, to a reduction in VEGF secretion and hence suppression of splenic angiogenesis and neovascularization.